BIOAGE targets aging to develop drugs that treat severe diseases
BIOAGE discovers and develops drugs to treat aging and associated diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 3, 2020 | Series C | $90M | 1 | — | — | Detail |
Jan 24, 2019 | Series B | $23M | 1 | — | — | Detail |